The plaintiffs were granted leave to refile after their class action complaint was dismissed on Iqbal grounds, but they decided not to, in a case that raises questions about the compatibility of Iqbal and class certification.

Cite as: Berks County v. First American Corp., 08 Civ. 5654 (LAK), NYLJ 1202471663410, at *1 (SDNY, Decided August 30, 2010)District Judge Lewis A. Kaplanp

Two months after opting out of a class action against Pfizer, a group of major public and private institutional investors are taking matters into their own hands. On Thursday the breakaway investors and their lawyers at Bernstein Litowitz filed their own securities fraud suit, accusing Pfizer of duping shareholders about risks associated with two once-blockbuster drugs.

A federal judge in Spokane took Robbins Geller to task last month over the firm's request for $2.1 million in fees and expenses related to a $7.5 million class action settlement, questioning whether two partners should be sanctioned or referred for disciplinary proceedings for overstating their expenses. The firm apologized Tuesday but defended much of its request.